Navigation Links
Untreatable Eye Disease Improves With Avastin

Patients with radiation retinopathy who were destined to go blind within five years now can keep their sight longer through localized treatment with Avastin , a well-known cancer drug, according to a two-year study published in the June, 2007 Archives of Ophthalmology.

This is a major breakthrough for eye cancer patients who are treated with radiation therapy and commonly develop radiation retinopathy, said Paul T. Finger, MD, lead author of the study and director of Ocular Tumor Services at the New York Eye and Ear Infirmary. Avastin reduces abnormal blood vessel growth, stops leakage in the eye and the patients wind up seeing better. This is a first.

Until now, patients with inflammation or cancer of the eyes choroid, retina, orbit and paranasal sinuses were confronted with a catch-22 in terms of treatment. Radiation therapy is the treatment of choice for most patients; but, it commonly causes a troubling side effect -- radiation retinopathy.

Dr. Finger references in the study 6 patients who had plaque radiation therapy and developed radiation retinopathy, but he has now treated 28 patients successfully with Avastin, he says. The drug improved or stabilized visual acuity in all cases by dramatically reducing blood vessel leakage and resultant swelling of the macula, the major causes of irreversible vision loss in radiation retinopathy, he said. He also noted that, before these Avastin findings, there was no effective treatment for macular radiation retinopathy.

Avastin is a monoclonal anti-body which inhibits the formation of abnormal blood vessels by selectively blocking a substance known as vascular endothelial growth factor (VEGF). Avasitin (also called bevaciaumab) is used systemically (throughout the body) for some cancers and has been linked to the risk of stroke; but, in this new study, it was administered and stayed locally in the eye.

In February 2007, in a study published in The America n Journal of Ophthalmology, Dr. Finger showed that treatment with Avastin had similar success in patients with radiation optic neuropathy.

The New York Eye and Ear Infirmary, the oldest specialty hospital in the Western Hemisphere, is the primary teaching hospital for the New York Medical College. It has approximately 142,000 outpatient visits annually and over 20,000 surgical procedures per year. It has one of the nations most extensive eye, ear, nose and throat clinics.


'"/>




Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Vitamins-The answer to Heart Disease?
3. Link between Constipation and Parkinsons Disease
4. Levels Of Blood Proteins May Help Heart Disease Care
5. New Drug PP188 Helps Sickle Cell Disease
6. Gene Treatment for Heart Disease
7. Legume Consumption Can Cut Heart Disease Risk
8. Link Between Infection And Heart Disease
9. Celiac Disease in Type 1 Diabetes
10. Shunt for Alzheimers Disease
11. High iron levels may cause Cardiovascular Disease in women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... , ... Advanced Spine & Sport Medical Rehabilitation Center, which is renowned for ... free seminar on stem cell injections. The seminar is scheduled for Wednesday, May 18, ... Road, Suite 110, Ventura, CA. There are only 10 seats available. , “The ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... knees, ankles, and elbows. Engineered with athletes in mind, OMNIFORCE offers high-performance, ... to ineffective circular knitting, common in the industry) produces premium flat-knit construction ...
(Date:5/4/2016)... ... May 03, 2016 – (PRWEB) ... infant and child products, today revealed the non-toxic benefits of its ... babies deal with teething pain is just part of the story. ... and are BPA-, PVC-, and phthalate-free. , “Many baby toys ...
(Date:5/4/2016)... ... 04, 2016 , ... With the stamp of approval from the United States ... National Cancer Research Month. According to the American Cancer Society (2016) , this ... one in four Americans dying as a result. , With numbers as influential as ...
(Date:5/4/2016)... ... ... Over 40 athletic trainer’s (ATs) and athletic training students (ATSs) from across ... advocacy day. The annual lobbying effort is a collaboration between the Pennsylvania Athletic ... the day was to educate the elected legislators and the public about the profession ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Keratosis Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Actinic ... Keratosis market valuations and forecast, Actinic Keratosis ...
(Date:5/3/2016)... 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen ... http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... 3, 2016   BIOTRONIK will be exhibiting ... beyond the implant at the Heart Rhythm Society,s 37 ... San Francisco . "Physicians ... quality of patient care and satisfaction possible. Part of ... and every tomorrow," said Marlou Janssen , President, ...
Breaking Medicine Technology: